Safety [R]Evolution is a ³Ô¹Ï±¬ÁÏ podcast that brings insights from Safety leaders with diverse backgrounds ¡ª life sciences organizations, technology and business consulting, CROs, and more. Discussing the importance of modernizing pharmacovigilance to deliver products quickly and safely to patients, each of our guests is interviewed by David Kolo?i?, Director of ³Ô¹Ï±¬ÁÏ Safety Strategy.
Subscribe to Safety [R]Evolution to get new episodes as soon as they are released.
Episode 7
The Safety Nucleus: From Compliance to Strategic Enabler
Host: David Kolo?i?, Director of ³Ô¹Ï±¬ÁÏ Safety StrategyGuest: Pav Rishiraj, Director, Head of Pharmacovigilance and UK QPPV, Ipsen
Ipsen¡¯s Pav Rishiraj joins David Kolo?i? to discuss why pharmacovigilance is the nucleus of the industry, and how moving from reactive to predictive safety will improve benefit-risk analysis and establish safety as a strategic enabler for the entire business.
Watch Video
Season 1
Episode 6
Humanizing PV: Better Patient Experience, Better Safety Data
In this episode of Safety [R]Evolution, Andrew Rut joins David Kolo?i? to discuss shifting PV from reactive data collection and reporting to a predictive, digital-first model that carefully considers the patient experience, integrates AI and automation, and positions safety as a competitive advantage.
Watch Video
Episode 5
Bringing Safety Operations and Science Together: Big Bang Approach
UCB¡¯s Adrian Maynier and ³Ô¹Ï±¬ÁÏ¡¯s Mayuran Croos join David Kolo?i? to discuss how to approach a ¡°big bang¡± consolidation of 17 siloed safety systems into one unified platform for case processing, reporting, signal detection, and content.
Watch Video
Episode 4
Building a Connected Safety Platform for the Future
David Kolo?i? speaks with ³Ô¹Ï±¬ÁÏ¡¯s Marius Mortensen about the long-term vision for ³Ô¹Ï±¬ÁÏ Safety; the benefits of starting with a trusted, validated cloud platform; and how a platform approach enables connected data and processes, advanced automation, and AI.
Watch Video
Episode 3
Strengthening Safety Oversight for CRO-Sponsor Partnerships
Biomapas¡¯ Martijn van de Leur and Olga Asimaki join David Kolo?i? to discuss the importance of CRO-sponsor partnerships in pharmacovigilance. They also talk about the need for simplification and standardization, progress on automation and AI, and how QPPV¡¯s are adapting to shifting technology.
Watch Video
Episode 2
Three Pillars of PV Transformation: Technology, Process, and People
In Episode 2, Eliquent Life Sciences¡¯ Emma-Jane Brookes and Jamie Portnoff speak with David Kolo?i? about simplifying and standardizing PV technology, harmonizing processes across teams and regions, and driving PV transformation through effective change management.
Watch Video
Episode 1
Building the Right Data and Technology Foundation for Safety
In our launch episode, David Kolo?i? talks with Sandoz¡¯s Aniket Agarwal about how the right data and technology foundation improves speed and operational efficiency for pharmacovigilance teams. We also discuss the benefits and challenges of automation and AI, and where rapidly evolving technologies will take safety in the future.
Watch Video
Reach out to David Kolo?i? if you would like to join the conversation or have ideas for upcoming episodes. We¡¯d like to hear from you!
See how companies like Merck, UCB, and Biomapas are driving safety transformation with a unified and connected pharmacovigilance solution.
